Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Fan

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Journal of Veterinary Internal Medicine|October 18, 2007
In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cellsDavid A Heller, Timothy M Fan, Louis-Philippe de Lorimier, et al.
Frontiers in Oncology|March 13, 2019
Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain CancersLisa J Schlein, Bahaa Fadl-Alla, Holly C Pondenis, et al.
American Journal of Veterinary Research|May 11, 2022
Three-dimensional hydrogel culture systems support growth and determination of chemosensitivity of feline sarcoma and carcinoma cell linesJacqueline V J Cavalcanti, Kimberly A Selting, Mai T Ngo, et al.
Molecular Pharmaceutics|April 11, 2012
Differential effects of procaspase-3 activating compounds in the induction of cancer cell deathDiana C West, Yan Qin, Quinn P Peterson, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
Neoplasia (New York, N.Y.)|July 11, 2021
Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapyAlycen P Lundberg, Matthew W Boudreau, Kim A Selting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2024
Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet DogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
ACS Central Science|March 3, 2025
Single Dose of a Small Molecule Leads to Complete Regressions of Large Breast Tumors in MiceMichael P Mulligan, Matthew W Boudreau, Brooke A Bouwens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2016
Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysisQian Yin, Li Tang, Kaimin Cai, et al.
Melanoma Research|September 22, 2023
The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanomaMatthew W Boudreau, Emily J Tonogai, Claire P Schane, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Journal of Veterinary Internal Medicine|October 18, 2007
In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cellsDavid A Heller, Timothy M Fan, Louis-Philippe de Lorimier, et al.
Frontiers in Oncology|March 13, 2019
Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain CancersLisa J Schlein, Bahaa Fadl-Alla, Holly C Pondenis, et al.
American Journal of Veterinary Research|May 11, 2022
Three-dimensional hydrogel culture systems support growth and determination of chemosensitivity of feline sarcoma and carcinoma cell linesJacqueline V J Cavalcanti, Kimberly A Selting, Mai T Ngo, et al.
Molecular Pharmaceutics|April 11, 2012
Differential effects of procaspase-3 activating compounds in the induction of cancer cell deathDiana C West, Yan Qin, Quinn P Peterson, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
Neoplasia (New York, N.Y.)|July 11, 2021
Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapyAlycen P Lundberg, Matthew W Boudreau, Kim A Selting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2024
Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet DogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
ACS Central Science|March 3, 2025
Single Dose of a Small Molecule Leads to Complete Regressions of Large Breast Tumors in MiceMichael P Mulligan, Matthew W Boudreau, Brooke A Bouwens, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2016
Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysisQian Yin, Li Tang, Kaimin Cai, et al.
Melanoma Research|September 22, 2023
The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanomaMatthew W Boudreau, Emily J Tonogai, Claire P Schane, et al.
Pageof 12